United States Healthcare Providers & Services

Elevance Health Inc (ELV)

Track

Over the past 90 days, Elevance Health Inc. saw 11 insider transactions totaling approximately $480,987 in net value. Notable activity includes significant share purchases by CEO Gail Boudreaux following the company's July earnings report, which exceeded expectations. Conversely, other insiders engaged in various sales and proposed sales, reflecting a mix of trading activity.
Ticker: ELV Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Elevance Health Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Buy 17 Jul 2026
Value US$958,880.97 | Price 70.81 | Shares 23,733 (+22.2%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-17 2026-07-17 B Purchase
3.6
PERU RAMIRO G
Non-Executive Director
23,733 +22.2%
70.81
US$958,881 		23,733 +22.2% 70.81 US$958,881
2026-07-17 2026-07-17 B Purchase
3.7
BOUDREAUX GAIL

President and CEO

Executive Director
85,340 +41.5%
296.59
US$4,680,046 		85,340 +41.5% 296.59 US$4,680,046
2026-07-17 2026-07-17 B Purchase
3.7
BOUDREAUX GAIL

President and CEO

Executive Director
19,772 -3.8%
101.90
US$379,023 		19,772 -3.8% 101.90 US$379,023
2026-07-07 2026-07-07 PrS Proposed sale
2.8
CLARK R KERRY

Director

Non-Executive Director
1,500
419.91
US$629,865 		1,500 419.91 US$629,865
2026-06-15 2026-06-12 S Sale
2.7
Penczek Ronald W

CAO & Controller

Officer
369 -9.0%
403.16
US$148,766 		369 -9.0% 403.16 US$148,766
2026-06-12 2026-06-12 PrS Proposed sale
2.7
RONALD WILLIAM PENCZEK

Officer

Officer
369
403.16
US$148,767 		369 403.16 US$148,767
2026-06-12 2026-06-11 S Sale
3.6
Dixon Robert L JR
Non-Executive Director
151 -1.4%
401.77
US$60,667 		151 -1.4% 401.77 US$60,667
2026-06-12 2026-06-11 S Sale
3.6
Dixon Robert L JR
Non-Executive Director
151 -1.4%
401.77
US$60,667 		151 -1.4% 401.77 US$60,667
2026-06-11 2026-06-11 PrS Proposed sale
3.6
Dixon Robert L JR

Director

Non-Executive Director
151
401.76
US$60,666 		151 401.76 US$60,666
2026-05-20 2026-05-19 S Sale
2.7
Penczek Ronald W

CAO & Controller

Officer
1,531 -27.1%
403.13
US$617,192 		1,531 -27.1% 403.13 US$617,192
2026-05-19 2026-05-19 PrS Proposed sale
2.7
RONALD WILLIAM PENCZEK

Officer

Officer
1,531
403.13
US$617,192 		1,531 403.13 US$617,192
2026-03-23 2026-03-12 S Sale
2.7
SCHULMAN AMY W
Non-Executive Director
26 -10.7%
287.50
US$7,475 		26 -10.7% 287.50 US$7,475
2026-03-09 2026-03-06 S Sale
3.2
Kendrick Charles Morgan JR

EVP & President, Commercial

Officer
3,196 -21.3%
284.92
US$910,604 		3,196 -21.3% 284.92 US$910,604
2026-03-06 2026-03-06 PrS Proposed sale
3.2
CHARLES MORGAN KENDRICK

Officer

Officer
3,196
284.92
US$910,593 		3,196 284.92 US$910,593
2026-03-06 2026-03-05 B Purchase
2.9
COLLIS STEVEN H
Non-Executive Director
3,000 +469.5%
289.84
US$869,520 		3,000 +469.5% 289.84 US$869,520
2025-08-21 2025-08-19 B Purchase
2.1
DeVore Susan D.
Non-Executive Director
1,200 +52.1%
312.15
US$374,580 		1,200 +52.1% 312.15 US$374,580
2025-07-18 2025-07-18 B Purchase
3.7
BOUDREAUX GAIL

President and CEO

Executive Director
1,050 +0.7%
287.96
US$302,358 		1,050 +0.7% 287.96 US$302,358
2025-07-18 2025-07-18 B Purchase
3.7
BOUDREAUX GAIL

President and CEO

Executive Director
5,116 +3.5%
287.12
US$1,468,906 		5,116 +3.5% 287.12 US$1,468,906
2025-07-18 2025-07-18 B Purchase
3.7
BOUDREAUX GAIL

President and CEO

Executive Director
2,334 +1.6%
286.07
US$667,687 		2,334 +1.6% 286.07 US$667,687
2025-04-25 2025-04-24 S Sale
2.7
Kaye Mark

EVP & CFO

Officer
4,588 -19.5%
424.82
US$1,949,074 		4,588 -19.5% 424.82 US$1,949,074
2025-04-24 2025-04-24 PrS Proposed sale
2.7
Kaye Mark

Officer

Officer
4,588
424.82
US$1,949,051 		4,588 424.82 US$1,949,051
2025-03-11 2025-03-10 S Sale
2.7
Penczek Ronald W

CAO & Controller

Officer
443 -19.3%
415.13
US$183,903 		443 -19.3% 415.13 US$183,903
2025-03-10 2025-03-10 PrS Proposed sale
2.7
Penczek Ronald W

Officer

Officer
443
415.13
US$183,904 		443 415.13 US$183,904
2025-03-05 2025-03-05 PrS Proposed sale
3.2
Kendrick Charles Morgan JR

Officer

Officer
3,504
396.30
US$1,388,651 		3,504 396.30 US$1,388,651
2025-03-05 2025-03-05 S Sale
3.2
Kendrick Charles Morgan JR

EVP & President, Commercial

Officer
3,504 -25.7%
396.30
US$1,388,635 		3,504 -25.7% 396.30 US$1,388,635
2024-10-18 2024-10-18 PrS Proposed sale
3.2
Kendrick Charles Morgan JR

Director

Non-Executive Director
7,417
432.28
US$3,206,221 		7,417 432.28 US$3,206,221
2024-10-18 2024-10-18 S Sale
3.2
Kendrick Charles Morgan JR

EVP & President, Commercial

Officer
7,417 -46.8%
432.14
US$3,205,182 		7,417 -46.8% 432.14 US$3,205,182
2024-08-06 2024-08-05 PlS Planned sale
3.6
PERU RAMIRO G
Non-Executive Director
753 -7.9%
531.52
US$400,235 		753 -7.9% 531.52 US$400,235
2024-08-05 2024-08-05 PrS Proposed sale
3.6
RAMIRO G PERU

Director

Non-Executive Director
753
531.52
US$400,235 		753 531.52 US$400,235
2024-07-23 2024-07-22 PlS Planned sale
3.7
BOUDREAUX GAIL

President and CEO

Executive Director
2,250 -1.7%
504.27
US$1,134,608 		2,250 -1.7% 504.27 US$1,134,608
2024-07-23 2024-07-22 PlS Planned sale
3.7
BOUDREAUX GAIL

President and CEO

Executive Director
1,000 -0.8%
503.67
US$503,670 		1,000 -0.8% 503.67 US$503,670
2024-07-23 2024-07-22 PlS Planned sale
3.7
BOUDREAUX GAIL

President and CEO

Executive Director
2,250 -1.7%
502.23
US$1,130,018 		2,250 -1.7% 502.23 US$1,130,018
2024-07-23 2024-07-22 PlS Planned sale
3.7
BOUDREAUX GAIL

President and CEO

Executive Director
6,621 -4.8%
501.40
US$3,319,769 		6,621 -4.8% 501.40 US$3,319,769
2024-07-23 2024-07-22 PlS Planned sale
3.7
BOUDREAUX GAIL

President and CEO

Executive Director
20,779 -13.0%
500.36
US$10,396,980 		20,779 -13.0% 500.36 US$10,396,980
2024-07-23 2024-07-22 PlS Planned sale
3.7
BOUDREAUX GAIL

President and CEO

Executive Director
1,100 -0.7%
498.50
US$548,350 		1,100 -0.7% 498.50 US$548,350
2024-07-22 2024-07-22 PrS Proposed sale
3.7
GAIL A KOZIARA BOUDREAUX

Officer; Director

Executive Director
34,000
500.98
US$17,033,398 		34,000 500.98 US$17,033,398
2024-07-22 2024-07-19 S Sale
3.6
Dixon Robert L JR
Non-Executive Director
305 -3.0%
506.76
US$154,562 		305 -3.0% 506.76 US$154,562
2024-07-19 2024-07-19 PrS Proposed sale
3.6
ROBERT DIXON

Director

Non-Executive Director
305
506.76
US$154,562 		305 506.76 US$154,562
2024-04-25 2024-04-24 S Sale
2.1
Norwood Felicia F

EVP & President,Gov Health Ben

Officer
3,434 -11.2%
532.68
US$1,829,223 		3,434 -11.2% 532.68 US$1,829,223
2024-04-25 2024-04-24 S Sale
2.1
Norwood Felicia F

EVP & President,Gov Health Ben

Officer
2,765 -8.3%
532.14
US$1,471,367 		2,765 -8.3% 532.14 US$1,471,367
2024-04-25 2024-04-23 S Sale
2.1
Norwood Felicia F

EVP & President,Gov Health Ben

Officer
100 -0.3%
534.74
US$53,474 		100 -0.3% 534.74 US$53,474
2024-04-25 2024-04-23 S Sale
2.1
Norwood Felicia F

EVP & President,Gov Health Ben

Officer
14,011 -30.7%
533.73
US$7,478,091 		14,011 -30.7% 533.73 US$7,478,091
2024-04-23 2024-04-23 PrS Proposed sale
2.1
Norwood Felicia F

Officer

Officer
20,310
533.60
US$10,837,416 		20,310 533.60 US$10,837,416
2024-03-12 2024-03-08 S Sale
3.2
Kendrick Charles Morgan JR

EVP & President, Commercial

Officer
2,432 -13.3%
500.46
US$1,217,119 		2,432 -13.3% 500.46 US$1,217,119
2024-03-08 2024-03-08 PrS Proposed sale
3.2
Kendrick Charles Morgan JR

Officer

Officer
2,432
500.46
US$1,217,119 		2,432 500.46 US$1,217,119
2024-03-08 2024-03-06 S Sale
2.7
Penczek Ronald W

CAO & Controller

Officer
916 -34.2%
504.58
US$462,195 		916 -34.2% 504.58 US$462,195
2024-03-06 2024-03-06 PrS Proposed sale
2.7
Penczek Ronald W

Officer

Officer
916
504.58
US$462,197 		916 504.58 US$462,197
2024-03-05 2024-03-04 PlS Planned sale
1.4
Haytaian Peter D

EVP & Pres Carelon & CarelonRx

Officer
15,000 -44.3%
500.18
US$7,502,700 		15,000 -44.3% 500.18 US$7,502,700
2024-03-05 2024-03-04 PlS Planned sale
1.4
Haytaian Peter D

EVP & Pres Carelon & CarelonRx

Officer
1,889 -5.3%
500.18
US$944,840 		1,889 -5.3% 500.18 US$944,840
2024-03-05 2024-03-04 PlS Planned sale
1.4
Haytaian Peter D

EVP & Pres Carelon & CarelonRx

Officer
4,206 -10.5%
500.18
US$2,103,757 		4,206 -10.5% 500.18 US$2,103,757
2024-03-04 2024-03-04 PrS Proposed sale
1.4
PETER D HAYTAIAN

Officer

Officer
21,095
500.18
US$10,551,297 		21,095 500.18 US$10,551,297
2024-02-09 2024-02-07 PlS Planned sale
3.6
PERU RAMIRO G
Non-Executive Director
753 -7.6%
500.00
US$376,500 		753 -7.6% 500.00 US$376,500
2024-02-07 2024-02-07 PrS Proposed sale
3.6
RAMIRO G PERU

Director

Non-Executive Director
753
500.00
US$376,500 		753 500.00 US$376,500
2023-12-15 2023-12-14 S Sale
1.6
Todt Blair Williams

EVP, CLO & CAO

Officer
5,492 -30.5%
484.02
US$2,658,238 		5,492 -30.5% 484.02 US$2,658,238
2023-12-14 2023-12-14 PrS Proposed sale
1.6
Todt Blair Williams

Officer

Officer
5,492
484.02
US$2,658,238 		5,492 484.02 US$2,658,238
2023-12-01 2023-11-30 S Sale
2.7
Penczek Ronald W

CAO & Controller

Officer
1,055 -37.1%
475.17
US$501,304 		1,055 -37.1% 475.17 US$501,304
2023-11-30 2023-11-30 PrS Proposed sale
2.7
Penczek Ronald W

Officer

Officer
1,055
475.17
US$501,300 		1,055 475.17 US$501,300
2023-10-26 2023-10-24 S Sale
2.7
Penczek Ronald W

CAO & Controller

Officer
64 -2.2%
454.35
US$29,078 		64 -2.2% 454.35 US$29,078
2023-07-21 2023-07-21 PrS Proposed sale
3.6
ROBERT DIXON JR

Director

Non-Executive Director
310
476.71
US$147,781 		310 476.71 US$147,781
2023-07-21 2023-07-21 S Sale
3.6
Dixon Robert L JR
Non-Executive Director
310 -3.1%
476.71
US$147,780 		310 -3.1% 476.71 US$147,780
2023-03-27 2023-03-24 PlS Planned sale
MCCARTHY GLORIA M

EVP & Chief Administrative Off

Officer
3,625 -6.6%
446.06
US$1,616,968 		3,625 -6.6% 446.06 US$1,616,968
2023-03-27 2023-03-24 PlS Planned sale
MCCARTHY GLORIA M

EVP & Chief Administrative Off

Officer
5,573 -9.2%
445.30
US$2,481,657 		5,573 -9.2% 445.30 US$2,481,657
2023-03-27 2023-03-24 PlS Planned sale
MCCARTHY GLORIA M

EVP & Chief Administrative Off

Officer
3,000 -4.7%
444.33
US$1,332,990 		3,000 -4.7% 444.33 US$1,332,990
2023-03-27 2023-03-24 PlS Planned sale
MCCARTHY GLORIA M

EVP & Chief Administrative Off

Officer
1,800 -2.8%
443.27
US$797,886 		1,800 -2.8% 443.27 US$797,886
2023-03-27 2023-03-24 PlS Planned sale
MCCARTHY GLORIA M

EVP & Chief Administrative Off

Officer
500 -0.8%
442.02
US$221,010 		500 -0.8% 442.02 US$221,010
2023-03-27 2023-03-24 PlS Planned sale
MCCARTHY GLORIA M

EVP & Chief Administrative Off

Officer
600 -0.9%
440.78
US$264,468 		600 -0.9% 440.78 US$264,468
2023-03-13 2023-03-09 S Sale
3.2
Kendrick Charles Morgan JR

EVP & President, Commercial

Officer
2,314 -13.1%
462.22
US$1,069,577 		2,314 -13.1% 462.22 US$1,069,577
2022-06-13 2022-06-09 S Sale
3.2
Kendrick Charles Morgan JR

EVP & President, Commercial

Officer
206 -1.4%
491.39
US$101,226 		206 -1.4% 491.39 US$101,226
2022-06-13 2022-06-09 S Sale
3.2
Kendrick Charles Morgan JR

EVP & President, Commercial

Officer
522 -3.4%
490.83
US$256,213 		522 -3.4% 490.83 US$256,213
2022-06-13 2022-06-09 S Sale
3.2
Kendrick Charles Morgan JR

EVP & President, Commercial

Officer
784 -4.9%
489.49
US$383,760 		784 -4.9% 489.49 US$383,760
2022-06-13 2022-06-09 S Sale
3.2
Kendrick Charles Morgan JR

EVP & President, Commercial

Officer
2,616 -14.0%
488.64
US$1,278,282 		2,616 -14.0% 488.64 US$1,278,282
2022-06-13 2022-06-09 S Sale
3.2
Kendrick Charles Morgan JR

EVP & President, Commercial

Officer
2,200 -10.5%
487.45
US$1,072,390 		2,200 -10.5% 487.45 US$1,072,390
2022-06-07 2022-06-06 S Sale
3.6
Dixon Robert L JR
Non-Executive Director
420 -4.2%
497.14
US$208,799 		420 -4.2% 497.14 US$208,799
2022-05-20 2022-05-19 PlS Planned sale
3.6
PERU RAMIRO G
Non-Executive Director
990 -9.5%
468.88
US$464,191 		990 -9.5% 468.88 US$464,191
2022-03-14 2022-03-10 PlS Planned sale
1.4
Haytaian Peter D

EVP & Pres., DBG & IngenioRx

Officer
40 -0.3%
463.40
US$18,536 		40 -0.3% 463.40 US$18,536
Explore more

More insider trading research around Elevance Health Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Providers & Services companies with insider activity
Insider trading in North America
Insider trades in S&P 500